In conclusion, it is possible that Gal-3 and CD74 proteins regulate independent survival pathways, but when both pathways are activated, this may enhance the survival of AML cells and lead to the worst prognosis in patients with AML (Figure 2). The gene discussed is LGALS3; the disease is acute myeloid leukemia.